MedTrace Logo

Exploring Sedation Types During Cataract Surgery

NCT04725747 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1111

Last updated 2026-05-04

No results posted yet for this study

Summary

This study is designed to explore the sedative and analgesic effectiveness of the Midazolam/Ketamine melt compared to IV sedation in subjects undergoing intraocular surgery.

Conditions

  • Vital Signs

Interventions

DRUG

Midazolam/Ketamine HCl 3mg-50mg sublingual

Single sublingual administration of Midazolam/Ketamine HCl 3mg-50mg sublingually prior to surgery

DRUG

Intravenous Sedatives with or Without Analgesia

Standard of Care

Sponsors & Collaborators

  • Vance Thompson Vision

    lead OTHER

Principal Investigators

  • John Berdahl, MD · Vance Thompson Vision Clinic Prof. LLC

Eligibility

Min Age
55 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-25
Primary Completion
2021-05-30
Completion
2021-06-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04725747 on ClinicalTrials.gov